The Gross Margin of Merrimack Pharmaceuticals Inc (MACK) is -194.15%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | -194.15% |